Pamela Landsman-Blumberg, DrPH, MPH
Senior Vice President
Real-World Evidence and HEOR Strategy
Magnolia Market Access
Connect with me
Pamela Landsman-Blumberg is Senior Vice President of Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) Strategy at Magnolia Innovation’s Market Access Division where she advises industry and trade associations on all aspects of fit-for-purpose real world data (RWD), RWE, and HEOR strategy.
Pam is an industry recognized subject matter expert in RWD evaluation and RWE generation. Her work designing and conducting outcomes research studies and implementing related strategies across the product lifecycle has improved the evidence- and value-based decision making of industry investors, C-suite members, payers, providers, and patients.
Prior to joining Magnolia, Pam worked at several consultancies and data providers building and growing HEOR and RWE divisions, advising clients on all aspects of fit-for-purpose RWD and RWE generation. In addition, Pam spent 13 years with Merck & Company in various HEOR, managed care marketing, and corporate health and wellness roles, all using RWD. She is a long-standing member of ISPOR and a past ISPOR Institutional Council Chair.
Pam holds a Master of Public Health in biostatistics from the University of North Carolina at Chapel Hill and a Doctor of Public Health in health policy and management from the University of Michigan at Ann Arbor.